⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
Mission BioCapital Announces Opening of $4 Million 2026 Platinum Program Contest and 2025 Platinum Ticket Investments
prnewswire.com
ABBV
LLY
Caliway Selected to Present Preclinical Data on CBL-514 in Combination with GLP-1R Therapy at the American Diabetes Association's 2026 Scientific Sessions
prnewswire.com
LLY
NVO
DIA's LIFT Series Brings Startup Pitch Competitions, Innovation Programming to Global Annual Meeting
prnewswire.com
LLY
ABBV
MRNA
FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions USA - English USA - English
prnewswire.com
LLY
FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions
prnewswire.com
LLY
AAVantgarde appoints Philip Lao as Senior Vice President of Business Development
globenewswire.com
LLY
Gemcitabine Hydrochloride Market Report 2026-2030 & 2035 Featuring Strategic Analysis of Fresenius Kabi, Eli Lilly and Company, Teva Pharma, Intas Pharma, Mylan and More
globenewswire.com
LLY
AZN
Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA
businesswire.com
CNTA
LLY
Nxera Pharma’s Partner Centessa Pharmaceuticals to be Acquired by Lilly
globenewswire.com
LLY
CNTA
Form 8-K
sec.gov
CNTA
LLY